Rate My Professor Kim Rice
Ratings & reviews
Always kind, respectful, and approachable.
A true role model for academic success.
Creates a collaborative learning environment.
Makes learning interactive and engaging.
Taught by or worked with Kim?
Add your rating. It takes about 30 seconds.
About Kim
Dr. Kim Rice is a Lecturer in Medical Genetics in the School of Medical, Molecular and Forensic Sciences at Murdoch University. She obtained her BSc in Molecular Biology from Murdoch University in 1998 and her PhD in Molecular Biology from the same university in 2004. Her primary research interests encompass leukaemia, haematological tumours, and epigenetics, with a particular emphasis on acute myeloid leukaemia (AML) and acute promyelocytic leukaemia (APL). Dr. Rice investigates precision therapies that target epigenetic regulators and leverage the immune system to eliminate leukaemia cells, aiming to develop more effective and less toxic treatments, especially for childhood AML.
Dr. Rice's professional career bridges academia, biotechnology, and intellectual property sectors. She supervises honours and PhD students and collaborates with institutions including The Kids Research Institute Australia, Harry Perkins Institute of Medical Research, Perth Children’s Hospital, and Fiona Stanley Hospital. Notable recent accomplishments include a fellowship funded by The Hospital Research Foundation and Cancer Council WA to advance precision therapies for paediatric AML, and a $139,845 grant from Cancer Council WA in 2026 for her project 'Empowering the immune system to fight acute myeloid leukaemia (AML)'. Key publications feature 'Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure' (2014, Nature Medicine), 'Comprehensive genomic screens identify a role for PLZF-RARα as a positive regulator of cell proliferation via direct regulation of c-MYC' (2009), 'FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias', and 'The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies' (2015). Her doctoral work resulted in publications in Blood, Genes & Development, and Blood Cancer Journal, and she has served as a reviewer for PNAS.
Trending Research & Publication News
SPARC Cost of Knowledge Study: 95% Public Investment in Articles
Photo by Precondo CA on Unsplash
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Informa Taylor & Francis Split & Clarion Deal | AcademicJobs
Photo by Anne Nygård on Unsplash
arXiv Two-Submission Monthly Cap Explained | AcademicJobs
Photo by Kelly Sikkema on Unsplash
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
Society Journal Sales & Nonprofit Consolidations | AcademicJobs
Photo by Philip Strong on Unsplash